Akums Drugs and Pharmaceuticals Limited (BOM:544222)

BOM:544222 Statistics

Total Valuation

BOM:544222 has a market cap or net worth of INR 81.95 billion. The enterprise value is 66.89 billion.

Market Cap	81.95B
Enterprise Value	66.89B

Important Dates

The last earnings date was Thursday, May 14, 2026.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	153.10M
Shares Outstanding	n/a
Shares Change (YoY)	+2.32%
Shares Change (QoQ)	-0.10%
Owned by Insiders (%)	35.44%
Owned by Institutions (%)	16.91%
Float	34.65M

Valuation Ratios

The trailing PE ratio is 32.11 and the forward PE ratio is 22.48.

PE Ratio	32.11
Forward PE	22.48
PS Ratio	1.88
PB Ratio	2.46
P/TBV Ratio	2.48
P/FCF Ratio	8.62
P/OCF Ratio	6.94
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.81, with an EV/FCF ratio of 7.04.

EV / Earnings	26.21
EV / Sales	1.53
EV / EBITDA	12.81
EV / EBIT	18.20
EV / FCF	7.04

Financial Position

The company has a current ratio of 3.25, with a Debt / Equity ratio of 0.05.

Current Ratio	3.25
Quick Ratio	2.26
Debt / Equity	0.05
Debt / EBITDA	0.30
Debt / FCF	0.17
Interest Coverage	3.91

Financial Efficiency

Return on equity (ROE) is 8.02% and return on invested capital (ROIC) is 14.45%.

Return on Equity (ROE)	8.02%
Return on Assets (ROA)	4.80%
Return on Invested Capital (ROIC)	14.45%
Return on Capital Employed (ROCE)	8.44%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	5.78M
Profits Per Employee	338,625
Employee Count	7,536
Asset Turnover	0.91
Inventory Turnover	3.50

Taxes

In the past 12 months, BOM:544222 has paid 1.26 billion in taxes.

Income Tax	1.26B
Effective Tax Rate	32.90%

Stock Price Statistics

The stock price has decreased by -8.44% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-8.44%
50-Day Moving Average	515.67
200-Day Moving Average	470.19
Relative Strength Index (RSI)	54.55
Average Volume (20 Days)	16,583

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:544222 had revenue of INR 43.59 billion and earned 2.55 billion in profits. Earnings per share was 16.67.

Revenue	43.59B
Gross Profit	18.45B
Operating Income	3.67B
Pretax Income	3.82B
Net Income	2.55B
EBITDA	5.22B
EBIT	3.67B
Earnings Per Share (EPS)	16.67

Balance Sheet

The company has 16.81 billion in cash and 1.57 billion in debt, with a net cash position of 15.23 billion.

Cash & Cash Equivalents	16.81B
Total Debt	1.57B
Net Cash	15.23B
Net Cash Per Share	n/a
Equity (Book Value)	33.31B
Book Value Per Share	216.55
Working Capital	24.65B

Cash Flow

In the last 12 months, operating cash flow was 11.81 billion and capital expenditures -2.31 billion, giving a free cash flow of 9.51 billion.

Operating Cash Flow	11.81B
Capital Expenditures	-2.31B
Depreciation & Amortization	1.55B
Net Borrowing	499.29M
Free Cash Flow	9.51B
FCF Per Share	n/a

Margins

Gross margin is 42.34%, with operating and profit margins of 8.43% and 5.85%.

Gross Margin	42.34%
Operating Margin	8.43%
Pretax Margin	8.77%
Profit Margin	5.85%
EBITDA Margin	11.98%
EBIT Margin	8.43%
FCF Margin	21.81%

Dividends & Yields

BOM:544222 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.32%
Shareholder Yield	-2.32%
Earnings Yield	3.11%
FCF Yield	11.60%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6